Anne Schuind

10PUBLICATIONS
50CO-AUTHORS
Preventative health careInnate immunityInfant and child healthEpidemiological methodsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 12, 2024
Human papillomavirus prophylactic vaccines: update on new vaccine development and implications for single-dose policy.

Anne E Schuind, Kanduri Ananth Balaji, Anna Du

|Aug 18, 2021
Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice.

Edward A Stadtmauer, Keith M Sullivan, Mohamed El Idrissi

|Jul 21, 2021
Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6-35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study.

Joon Hyung Kim, Mamadou Drame, Thanyawee Puthanakit

|Jun 30, 2021
Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview.

Alemnew F Dagnew, Peter Vink, Mamadou Drame

|Feb 19, 2021
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials.

Joon Hyung Kim, John Diaz-Decaro, Ning Jiang

|Sep 05, 2020
Non-neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system.

Damien Friel, Mary Co, Thierry Ollinger

Pageof 2

Frequent Collaborators

4 joint publications

Bruno Salaun

3 joint publications

Joon Hyung Kim

2 joint publications

Alemnew F Dagnew

2 joint publications

Gael Dos Santos